Oral Answers to Questions

Andrew Lewer Excerpts
Tuesday 20th March 2018

(6 years, 1 month ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Steve Brine Portrait Steve Brine
- Hansard - - - Excerpts

I will look at Hightown surgery, and if the hon. Gentleman wants to talk to me about it, he is welcome to do so. Of course it is the responsibility of his clinical commissioning group and NHS England in his area to provide primary care services for the patients who are his constituents, but if wants to talk to me further, I am very happy to do so.

Andrew Lewer Portrait Andrew Lewer (Northampton South) (Con)
- Hansard - -

T1. If he will make a statement on his departmental responsibilities.

Jeremy Hunt Portrait The Secretary of State for Health and Social Care (Mr Jeremy Hunt)
- Hansard - - - Excerpts

Following the Government’s commitment to expand medical school places by 25%—one of the biggest expansions in the history of the NHS—I am pleased to announce to the House the results of the competition to set up five new medical schools. They were chosen following a rigorous and independent bidding process, which prioritised attracting doctors to harder-to-recruit areas and increasing the number of GPs and psychiatrists. Many congratulations to the winners, which are: the University of Sunderland; Edge Hill University in Lancashire; Anglia Ruskin University in Chelmsford; the University of Lincoln working in collaboration with Nottingham University; and Canterbury Christ Church University.

Andrew Lewer Portrait Andrew Lewer
- Hansard - -

With the death of Professor Stephen Hawking in all of our thoughts, can the Minister tell us what steps his Department will take to support research to develop a cure for motor neurone disease?

Jeremy Hunt Portrait Mr Hunt
- Hansard - - - Excerpts

Professor Hawking was an inspiration not just because of his scientific thinking, but because, to many people with motor neurone disease, he was an absolute exemplar: he was given two years to live at the age of 21 and ended up living until he was 76. This disease is a big area of priority for us. In the last year for which we have full-year figures, £52 million was invested into it, and we are currently recruiting for 24 clinical trials.